Literature DB >> 24977000

Levels of 1,25(OH)2D3 for patients with pulmonary tuberculosis and correlations of 1,25(OH)2D3 with the clinical features of TB.

Wei-Wei Gao1, Yu Wang1, Xiang-Rong Zhang1, Chun-Yang Yin1, Chun-Mei Hu1, Man Tian1, Hong-Wei Wang1, Xia Zhang1.   

Abstract

BACKGROUND: To determine the 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] concentrations to patients with tuberculosis (TB) and whether it influenced the patient's clinical features.
METHODS: For the first part, a total of 153 healthy adults and 74 patients with pulmonary TB (PTB) were enrolled. Serum concentrations of 1,25(OH)2D3 were determined by liquid chromatography-tandem mass spectroscopy to examine the 1,25(OH)2D3 concentrations of the two groups from the peripheral blood. If there are differences between the two groups, what follow will increase the experimental group numbers to examine the relationship among the 1,25(OH)2D3 concentrations with the numbers of the lesion area, the tubercule bacilli in sputum and the CD4/CD8 ratio of T lymphocytes in the peripheral blood.
RESULTS: In the first part, the 1,25(OH)2D3 concentrations was lower in patients with TB than in those healthy adults [365.9 (SD 235.7) vs. 464.3 (SD 335.6), P<0.05]. In the second part, we increased the sample size to 134 (male 91 cases, female 43 cases). we found that the plasma levels of 1,25(OH)2D3 are not correlated with the numbers of the lesion area and the tubercule bacilli in sputum, but the 1,25(OH)2D3 levels can interact the ratio of CD4/CD8 T lymphocytes, it shows a positive correlation with the ratio of CD4/CD8 T lymphocytes.
CONCLUSIONS: The 1,25(OH)2D3 concentrations in TB patients lower than the healthy adults, it might exist as a risk factor during the development of TB or TB might affect the levels of 1,25(OH)2D3. But the different status vitamin D concentration might not affect the numbers of the lesion area, the tubercule bacilli in sputum. It shows a positive correlation with the ratio of CD4/CD8 T lymphocytes. The study will have a significance value to clinical medicine, but further study will need to study the levels of 1,25(OH)2D3 with the TB.

Entities:  

Keywords:  1,25-dihydroxyvitamin D3 [1,25(OH)2D3]; CD4/CD8 T lymphocytes; Tuberculosis (TB); clinical features

Year:  2014        PMID: 24977000      PMCID: PMC4073399          DOI: 10.3978/j.issn.2072-1439.2014.05.12

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  23 in total

1.  Targeting dietary vitamin D intakes and plasma 25-hydroxyvitamin D in healthy infants.

Authors:  Steven A Abrams
Journal:  JAMA       Date:  2013-05-01       Impact factor: 56.272

2.  Variability and reproducibility of circulating vitamin D in a nationwide U.S. population.

Authors:  Jacqueline M Major; Barry I Graubard; Kevin W Dodd; Allison Iwan; Bruce H Alexander; Martha S Linet; D Michal Freedman
Journal:  J Clin Endocrinol Metab       Date:  2012-11-08       Impact factor: 5.958

3.  Prevalence and severity of vitamin D deficiency in patients with diabetic foot infection.

Authors:  Shalbha Tiwari; Daliparthy D Pratyush; Balram Gupta; Awanindra Dwivedi; Sandeep Chaudhary; Rammohan K Rayicherla; Sanjeev K Gupta; Surya Kumar Singh
Journal:  Br J Nutr       Date:  2012-04-03       Impact factor: 3.718

4.  Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages.

Authors:  Mario Fabri; Steffen Stenger; Dong-Min Shin; Jae-Min Yuk; Philip T Liu; Susan Realegeno; Hye-Mi Lee; Stephan R Krutzik; Mirjam Schenk; Peter A Sieling; Rosane Teles; Dennis Montoya; Shankar S Iyer; Heiko Bruns; David M Lewinsohn; Bruce W Hollis; Martin Hewison; John S Adams; Andreas Steinmeyer; Ulrich Zügel; Genhong Cheng; Eun-Kyeong Jo; Barry R Bloom; Robert L Modlin
Journal:  Sci Transl Med       Date:  2011-10-12       Impact factor: 17.956

5.  Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation.

Authors:  Rachael M Biancuzzo; Nigel Clarke; Richard E Reitz; Thomas G Travison; Michael F Holick
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

6.  Vitamin D3 and the immune system: maintaining the balance in health and disease.

Authors:  Femke Baeke; Evelyne Van Etten; Lut Overbergh; Chantal Mathieu
Journal:  Nutr Res Rev       Date:  2007-06       Impact factor: 7.800

7.  Vitamin D-dependent cathelicidin inhibits Mycobacterium marinum infection in human monocytic cells.

Authors:  Emi Sato; Shinichi Imafuku; Kazunari Ishii; Ryota Itoh; Bin Chou; Toshinori Soejima; Juichiro Nakayama; Kenji Hiromatsu
Journal:  J Dermatol Sci       Date:  2013-02-09       Impact factor: 4.563

8.  Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin d receptor and cathelicidin in pulmonary tuberculosis.

Authors:  P Selvaraj; S Prabhu Anand; M Harishankar; K Alagarasu
Journal:  J Clin Immunol       Date:  2009-02-14       Impact factor: 8.317

9.  Vitamin D status in female students and its relation to calcium metabolism markers, lifestyles, and polymorphism in vitamin D receptor.

Authors:  Zahra Jamali; Gholamreza Asadikaram; Mehdi Mahmoodi; Ahmadreza Sayadi; Ahmad Jamalizadeh; Masoud Saleh-Moghadam; Majid Sirati-Sabt; Mohammad Kazemi Arababadi
Journal:  Clin Lab       Date:  2013       Impact factor: 1.138

10.  Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis'.

Authors:  Nawal Salahuddin; Farheen Ali; Zahra Hasan; Nisar Rao; Masooma Aqeel; Faisal Mahmood
Journal:  BMC Infect Dis       Date:  2013-01-19       Impact factor: 3.090

View more
  4 in total

1.  Vitamin D improves immune function in immunosuppressant mice induced by glucocorticoid.

Authors:  Zongye Wang; Ying Wang; Bingxin Xu; Junli Liu; Ye Ren; Zhuojie Dai; Di Cui; Xiaoming Su; Shaoyan Si; Shu Jun Song
Journal:  Biomed Rep       Date:  2016-11-24

2.  Vitamin D deficiency and the risk of tuberculosis: a meta-analysis.

Authors:  Shao-Jun Huang; Xian-Hua Wang; Zhi-Dong Liu; Wen-Li Cao; Yi Han; Ai-Guo Ma; Shao-Fa Xu
Journal:  Drug Des Devel Ther       Date:  2016-12-28       Impact factor: 4.162

3.  Changes in T-lymphocyte subsets and risk factors in human immunodeficiency virus-negative patients with active tuberculosis.

Authors:  Kui Li; Renyu Ran; Zicheng Jiang; Chuanqi Fan; Tao Li; Zhiguo Yin
Journal:  Infection       Date:  2020-05-29       Impact factor: 3.553

4.  Hypovitaminosis D among newly diagnosed pulmonary TB patients and their household contacts in Uganda.

Authors:  Ester Lilian Acen; Irene Andia Biraro; Mudarshiru Bbuye; David Patrick Kateete; Moses L Joloba; William Worodria
Journal:  Sci Rep       Date:  2022-03-28       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.